Advanced Biotech Research Solutions
Our goal has always been to research, develop and eventually manufacture quality aerosol products. The company was founded under the simple premise of finding biologics that are safe and effective for common patient indications and deliver them in trusted aerosol
delivery devices.
For the first few years, NUTRA spent time researching and developing a formulation that could be leveraged in a metered dose inhaler (MDI). The result was three different semi-synthetic cannabinoid formulations NUTRA believes will revolutionize the use of MDIs with cannabinoids. The development of the formulations and MDIs were based on the belief that these products could be used for legitimate medical needs. NUTRA built the products to provide patients and providers an option that would give accurate dosing, use pharmaceutical grade ingredients, provide relief quickly, and deliver the most systematically
available dose possible.
Our Differentiators
Superior Delivery System with Proven Efficacy
History. MDIs have been in use for over 70 years and
are the best way to get safe to use inhalants into a
user’s blood stream outside of an IV. NUTRA has
spent substantial time and resources perfecting the
technology to ensure that its devices operate as
designed. This involves ensuring the parts and
machines are pharmaceutical grade, its lab is up to
GMP standards, dosing is accurate and measured
and API are the highest medical quality. In short, the
MDI NUTRA builds are believed to be safe and
unadulterated.
Proprietary Active Pharmaceutical Ingredients
(API). NUTRA has five formulations that allow them to be easily used in a pMDI device
Market Knowledge and Understanding. With over 30
years combined experience in the development of
NPC API, NUTRA’s team has a high level of industry
knowledge. The current team has vast experience
and extensive industry contacts to assist in the
procurement of raw materials in the hemp space.
Company management has experience building,
scaling and taking businesses public. NUTRA’s team
has extensive technical expertise in the
manufacturing of API and metered dose inhalers. In
addition, staff is experienced in consumer
deliverables and training.
